Account-based marketing for startups under 20 people for healthcare and life sciences
How under-20-person startups get account-based marketing live without hiring — the specific version of the playbook designed for constraint. Written for commercial leaders at healthtech, medtech, and life-sciences companies.
This edition is written for commercial leaders at healthtech, medtech, and life-sciences companies. In healthcare and life sciences, healthcare buyers move under regulatory constraint and reward domain-specific messaging, so the way you install account-based marketing has to reflect that reality from day one.
The under-20-person version of account-based marketing is not a diluted enterprise playbook. It is concentrating marketing on a named list of accounts with tailored plays with different constraints: no headcount, no politics, and no time to be wrong for long.
Own it personally as a founder or lean-in operator for the first quarter. Hiring a specialist too early replaces context with process.
Pick one channel, one trigger, one message. Two of anything at this stage is too many and none of them will work.
The binding constraint we see in healthcare and life sciences is almost always regulated-sale cycle length, not intent. Account-based marketing is only useful in this vertical when it is pointed at that constraint — not at a generic growth number borrowed from another category.
Instrument pipeline created inside the named-account list in a spreadsheet if you have to. Legibility beats sophistication under 20 people.
The startup-specific trap is confusing ABM with lead scoring on inbound MQLs, usually because a well-meaning advisor points at what worked at their $50m company. Ignore.
Budget rules: whatever you spend on tools, spend the same on the person operating them. Under-tooling is fine; under-humaning is not.
A working account-based marketing function at 15 people is a genuine moat — most competitors of that size do not have one, and the discipline carries forward as the company grows.
Concretely for healthcare and life sciences: the healthcare teams that install this get past procurement instead of dying in it. That is the reason it is worth installing account-based marketing properly rather than half-heartedly across three vendors.
Frequently asked questions
ABM · healthcare — answered
- Does account-based marketing work for healthcare and life sciences?
- Yes — provided it is aimed at regulated-sale cycle length, not intent rather than a generic growth number. The healthcare teams that install this get past procurement instead of dying in it.
- Can a five-person team run account-based marketing?
- Yes, if the founder owns it. The lower headcount, the more concentrated the ownership.
- What is the smallest useful account-based marketing setup?
- One channel, one trigger, one message, and a spreadsheet tracking pipeline created inside the named-account list.
- Should we hire a specialist for account-based marketing?
- Not in the first quarter. Own it personally until the model is proven.
- What common advice should startups ignore?
- Anything derived from a company more than 10x larger. Constraints differ.
- What is the healthcare specific pitfall with account-based marketing?
- Running the generic playbook without adapting to healthcare buyers move under regulatory constraint and reward domain-specific messaging. The install has to be vertical-first.
Growth Broker editorial
Filed under abm · healthcare